A recently discovered inhibitor shows new ways for the development of mRNA-based drugs.mRNA-based therapeutics and vaccines ...

RNA-based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

This interesting study focuses on a previously reported positive correlation between translational efficiency and protein noise. This is unexpected as typically noise is inversely related to ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

CAMBRIDGE, MA / ACCESSWIRE / October 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 7 ...

About half a million people in the U.S. contract C ... Now, researchers have developed an mRNA vaccine that protected mice from succumbing to C. diff infections and prevented recurring cases.

A team of researchers at the University of Pennsylvania took a new approach, using mRNA technology to design a multipronged vaccine that targets several proteins that underlie C. difficile’s ...

with contributions expected to materialize in the second half of 2024. Maravai continues to make progress in addressing the complete mRNA workflow through new product introductions. A notable ...